Nervgen Pharma NGEN
NASDAQ NGEN
$1.43 +0.01 (+0.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Other non-cash items (2025 - 2026)

Updated

Analysis

Nervgen Pharma (NGEN) Other non-cash items (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Nervgen Pharma 113.90 Mn 12.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.59 Mn
Mar 31, 2026 53,230.56
Jun 30, 2025 -60,498.27
Mar 31, 2025 -3,512.46
API Access

Nervgen Pharma Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=NGEN&period=max&api_key=YOUR_API_KEY